First-Line Pembrolizumab plus Axitinib Combination Boosts Survival in Metastatic Renal Cell Carcinoma.

Authors :: Powles, Thomas
Pal, Sumanta K.
Wood, Lori
Source :: Journal of Oncology Navigation & Survivorship; Aug2019, Vol. 10 Issue 8, p317-318, 2p
Publication Year :: 2019

Subjects :: BENZAMIDE
THERAPEUTIC use of monoclonal antibodies
PREVENTION of disease progression
ANTINEOPLASTIC agents
METASTASIS
RENAL cell carcinoma
SURVIVAL
PROTEIN-tyrosine kinase inhibitors
VASCULAR endothelial growth factors
TREATMENT effectiveness
THERAPEUTICS
PROGNOSIS

Tools